CADASIL Clinical Trial - CADASIL Registry Study

Status Recruiting

Clinical Trial Summary

The aim of this study is to determine the clinical spectrum and natural progression of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) and related disorders in a prospective multicenter study, to assess the clinical, genetic and epigenetic features of patients with CADASIL , to optimize clinical management.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04310098
Study type	Observational
Source	First Affiliated Hospital of Fujian Medical University
Contact	Lin Yi, PhD
Phone	13615039153
Email	caibin929@163.com
Status	Recruiting
Phase
Start date	March 9, 2020
Completion date	March 9, 2049

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT03724136` - Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study	N/A
Recruiting	`NCT05755997` - CERebrolysin In CADASIL	Phase 2
Recruiting	`NCT06148051` - AusCADASIL: An Australian Cohort of CADASIL
Completed	`NCT01114815` - Research Study on Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)	N/A
Recruiting	`NCT05677880` - Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
Recruiting	`NCT02795052` - Neurologic Stem Cell Treatment Study	N/A
Completed	`NCT02837354` - The Silent Cortical Infarcts in the Cerebral Amyloid Angiopathy: Is There a Link With Subarachnoid Hemorrhage?	N/A
Recruiting	`NCT01361763` - Safety Study of Dabigatran in CADASIL	Phase 2
Completed	`NCT02071784` - Imaging Study of Neurovascular Coupling in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Completed	`NCT06072118` - Adrenomedullin for CADASIL	Phase 2
Active, not recruiting	`NCT02699190` - LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
Recruiting	`NCT05473637` - Taiwan Associated Genetic and Nongenetic Small Vessel Disease
Enrolling by invitation	`NCT02032225` - Generation of a Cellular Model of CADASIL From Skin Fibroblasts	N/A
Recruiting	`NCT03047369` - The Myelin Disorders Biorepository Project
Active, not recruiting	`NCT04658823` - Efficacy and Safety of Tocotrienols in CADASIL	Phase 2
Withdrawn	`NCT04334408` - Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL	Phase 2
Recruiting	`NCT05734378` - Prognosis of Cerebral Small Vessel Disease
Recruiting	`NCT05491980` - Florida Cerebrovascular Disease Biorepository and Genomics Center
Recruiting	`NCT04036084` - Development of New Biomarkers With Magnetic Resonance Imaging for Longitudinal Studies in CADASIL Angiopathy
Completed	`NCT01865604` - Impact of tDCS on Cerebral Autoregulation	N/A